The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS, INC | COM | 015351909 | 78,215 | 569,500 | SH | Call | SOLE | 569,500 | 0 | 0 | |
EDITAS MEDICINE INC COM | COM | 28106W903 | 4,315 | 255,000 | SH | Call | SOLE | 255,000 | 0 | 0 | |
GILEAD SCIENCES INC | COM | 375558903 | 38,045 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
VERTEX PHARMACEUTICALS INC | COM | 92532F900 | 9,109 | 60,000 | SH | Call | SOLE | 60,000 | 0 | 0 | |
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 41,157 | 1,482,600 | SH | SOLE | 1,482,600 | 0 | 0 | ||
GALAPAGOS NV SPON ADR | SPONSORED ADR | 36315X101 | 44,267 | 578,505 | SH | SOLE | 578,505 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 3,410 | 742,835 | SH | SOLE | 742,835 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 5,030 | 185,472 | SH | SOLE | 185,472 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 2,186 | 874,447 | SH | SOLE | 874,447 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,199 | 23,300 | SH | SOLE | 23,300 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 60,776 | 2,943,164 | SH | SOLE | 2,943,164 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG CO LTD | COM | G11196105 | 1,750 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 951 | 17,060 | SH | SOLE | 17,060 | 0 | 0 | ||
CASCADIAN THERAPEUTICS INC | COM | 14740B606 | 11,145 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 1,104 | 118,000 | SH | SOLE | 118,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 936 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 9,741 | 805,000 | SH | SOLE | 805,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 12,322 | 794,969 | SH | SOLE | 794,969 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 2,435 | 767,992 | SH | SOLE | 767,992 | 0 | 0 | ||
EDITAS MEDICINE INC COM | COM | 28106W103 | 12,033 | 717,107 | SH | SOLE | 717,107 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 8,220 | 2,537,026 | SH | SOLE | 2,537,026 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 51,210 | 1,585,457 | SH | SOLE | 1,585,457 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 70,869 | 3,753,635 | SH | SOLE | 3,753,635 | 0 | 0 | ||
KINDRED BIOSCIENCES INC | COM | 494577109 | 4,686 | 544,880 | SH | SOLE | 544,880 | 0 | 0 | ||
KURA ONCOLOGY INC COM | COM | 50127T109 | 18,913 | 2,033,622 | SH | SOLE | 2,033,622 | 0 | 0 | ||
ATYR PHARMA INC | COM | 002120103 | 7,795 | 2,292,659 | SH | SOLE | 2,292,659 | 0 | 0 | ||
NABRIVA THERAPEUTICS | COM | G63637105 | 2,775 | 264,773 | SH | SOLE | 264,773 | 0 | 0 | ||
MINERVA NEUROSCIENCES INC | COM | 603380106 | 1,981 | 223,802 | SH | SOLE | 223,802 | 0 | 0 | ||
OVASCIENCE INC | COM | 69014Q101 | 5,479 | 3,512,332 | SH | SOLE | 3,512,332 | 0 | 0 | ||
ARATANA THERAPEUTICS INC | COM | 03874P101 | 723 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K101 | 3,656 | 3,709,144 | SH | SOLE | 3,709,144 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 776 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
SANGAMO BIOSCIENCES INC | COM | 800677106 | 22,599 | 2,568,119 | SH | SOLE | 2,568,119 | 0 | 0 | ||
TOCAGEN INC | COM | 888846102 | 18,074 | 1,502,373 | SH | SOLE | 1,502,373 | 0 | 0 | ||
TETRAPHASE PHARMACEUTICALS INC | COM | 88165N105 | 4,516 | 633,400 | SH | SOLE | 633,400 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 831 | 10,425 | SH | SOLE | 10,425 | 0 | 0 |